BlueRock Therapeutics società ha sostenuto
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
leggi di più
Great company to work for! Inspiring mission to urgently bring cell therapy treatments to patients, extremely passionate, knowledgeable and friendly colleagues, and great opportunities to grow professionally!
Quali sono alcune delle cose migliori della tuo team?
Highly motivated, high energy, passionate, knowledgeable, friendly
Cosa ti piace di più del team di leadership?
Innovative, strategic, investing in employee development
La cosa più positiva della cultura e l'ambiente presso la tua azienda?
High energy, very friendly and collaborative
Qual è la parte migliore del tuo compenso?
Milestone related bonus compensation packages
Che cosa ti rende più felice sul posto di lavoro?
Our moonshot mission to deliver on the promise of cell therapies now
Other Employee Reviews for BlueRock Therapeutics
×